Quantitative RT-PCR
Quantitative reverse-transcription-polymerase chain reaction (qRT-PCR) was performed as previously described (2) . Briefly, first-strand cDNA was synthesized with the use of ImProm II reverse transcription system (Promega, Madison, WI) and then subjected to quantitative PCR with the use of a LightCycler 480 system (Roche, Indianapolis, IN). The PCR primer sequences for C/EBPalpha are TGT ATA CCC CTG GTG GGA GA and TCA TAA CTC CGG TCC CTC TG; for TMEM166 are AGC AAC ATC CTA GCG GCC TA and TGT GTG GCA AGA GAT CCT TAT CA; for β-actin are GGA CTT CGA GCA AGA GAT GG and AGC ACT GTG TTG GCG TAC AG, and for SFRS4 are AAA AGT CGG AGC AGG AGT CA and CTC TTC CTG CCC TTC CTC TT.
DNA sequencing for CEBPA mutations
The DNA sequencing for CEBPA mutations in the genomic coding region was carried out from 26 pairs of primary HCCs and 5 HCC cell lines, as described previously.
1 Triplicates of DNA sequencing was conducted to ensure the robustness of the data,
Transcriptome analysis
The transcriptome analysis was conducted as described previously. 2 Briefly, total RNA was extracted from C/EBPalpha-expressing Hep3B and stable shNC, C/EBPalpha-deficient HepG2 and HCC-M, and C/EBPalpha-silenced stable sh4 and sh7 cells. The mRNAs from each cell lines were reversibly transcribed by Genechip 3'IVT Express kit (Affymetrix, Santa
Cruz, CA) and biotin labeled. The final cDNAs were hybridized to human HG-U1331 and HG-U133-B oligonucleotide probe arrays (Affymetrix) according to the manufacturer's instructions. 
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